Maternal vitamin D tied to risk of small for gestational age

Maternal vitamin D tied to risk of small for gestational age

(HealthDay)—Maternal serum 25-hydroxyvitamin D concentration is associated with the risk of small-for-gestational-age (SGA) offspring, according to a study published online Dec. 6 in Obstetrics & Gynecology.

Alison D. Gernand, Ph.D., M.P.H., R.D., from the University of Pittsburgh Graduate School of Public Health, and colleagues assayed serum samples at 12 to 26 weeks of gestation for 25-hydroxyvitamin D in 792 participants in a trial of low-dose aspirin for prevention of preeclampsia in high-risk women. After adjustment for confounders, including maternal pre-pregnancy obesity, race, treatment allocation, and risk group, the correlation between 25-hydroxyvitamin D and the risk of SGA was assessed.

The researchers found that, at birth, 13 percent of neonates were SGA. Women who delivered SGA had lower 25-hydroxyvitamin D concentrations (57.9 nmol/L) than those with non-SGA neonates (64.8 nmol/L; P = 0.028). Compared with 25-hydroxyvitamin-D concentrations of <30 nmol/L, the risk of SGA was reduced by 43 percent with concentrations of 50 to 74 nmol/L and by 54 percent with concentrations of 75 nmol/L or greater, in adjusted models. This association was modified by race and maternal obesity. The risk of SGA was significantly reduced by 68 and 50 percent, respectively, for white and non-obese women with 25-hydroxyvitamin D of 50 nmol/L or greater versus <50 nmol/L. In black or obese women, 25-hydroxyvitamin D was not associated with the risk of SGA.

"Maternal vitamin D status in the second trimester is associated with risk of SGA among all women and in the subgroups of white and non-obese women," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Nutrition type affects endocrinology in SGA infants

Aug 01, 2012

(HealthDay) -- Small-for-gestational-age (SGA) infants who are formula-fed (FOF) have elevated endocrine levels of high-molecular-weight (HMW) adiponectin and insulin growth factor-I (IGF-I) compared with ...

Recommended for you

Majority of women report sexual dysfunction after childbirth

6 hours ago

Many women notice that their sexual health changes after childbirth, according to researchers from Loyola University Chicago. Loyola researchers have a study under way to determine the extent to which pelvic pain may be related ...

Is egg freezing an empowering option for women?

Nov 17, 2014

Katie Hammond, a PhD candidate in the Department of Sociology researching the experience of egg donation in Canada, discusses the recent decision by tech giants Facebook and Apple to offer egg freezing to ...

Peripheral nerve blocks OK for migraines in pregnancy

Nov 14, 2014

(HealthDay)—For migraines that do not respond to medications, peripheral nerve blocks may be a treatment option in pregnant women, according to research published online Nov. 5 in Obstetrics & Gynecology.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.